Skip to main content
Top
Published in: Infectious Diseases and Therapy 1/2015

Open Access 01-09-2015 | Review

Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists

Authors: Mark Gilchrist, Paul Wade, Diane Ashiru-Oredope, Philip Howard, Jacqueline Sneddon, Laura Whitney, Hayley Wickens

Published in: Infectious Diseases and Therapy | Special Issue 1/2015

Login to get access

Abstract

Antimicrobial stewardship in the UK has evolved dramatically in the last 15 years. Factors driving this include initial central funding for specialist pharmacists and mandatory reductions in healthcare-associated infections (particularly Clostridium difficile infection). More recently, the introduction of national stewardship guidelines, and an increased focus on stewardship as part of the UK five-year antimicrobial resistance strategy, have accelerated and embedded developments. Antimicrobial pharmacists have been instrumental in effecting changes at an organizational and national level. This article describes the evolution of the antimicrobial pharmacist role, its impact, the progress toward the actions listed in the five-year resistance strategy, and novel emerging areas in stewardship in the UK.
Literature
1.
go back to reference Department of Health. Getting ahead of the curve: a strategy for combating infectious diseases (including other aspects of health protection). 2002. Department of Health. Getting ahead of the curve: a strategy for combating infectious diseases (including other aspects of health protection). 2002.
2.
go back to reference Department of Health. Winning ways: working together to reduce healthcare associated infection in England. 2003. Department of Health. Winning ways: working together to reduce healthcare associated infection in England. 2003.
3.
go back to reference National Audit Office. Reducing healthcare associated infections in hospitals in England. 2009. National Audit Office. Reducing healthcare associated infections in hospitals in England. 2009.
4.
go back to reference Department of Health. Annual epidemiological commentary: mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data. 2013/14. Department of Health. Annual epidemiological commentary: mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data. 2013/14.
7.
go back to reference Department of Health. PL CMO (2003) 3: Hospital Pharmacy initiative for promoting prudent use of antibiotics in hospitals. 2003. Department of Health. PL CMO (2003) 3: Hospital Pharmacy initiative for promoting prudent use of antibiotics in hospitals. 2003.
8.
go back to reference Wickens HJ, Jacklin A. Impact of the hospital pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England. J Antimicrob Chemother. 2006;58:1230–7.CrossRefPubMed Wickens HJ, Jacklin A. Impact of the hospital pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England. J Antimicrob Chemother. 2006;58:1230–7.CrossRefPubMed
9.
go back to reference Hand K. Antibiotic pharmacists in the ascendancy. J Antimicrob Chemother. 2007;60(Suppl 1):i73–6.CrossRefPubMed Hand K. Antibiotic pharmacists in the ascendancy. J Antimicrob Chemother. 2007;60(Suppl 1):i73–6.CrossRefPubMed
10.
go back to reference Ansari F, Gray K, Nathwani D, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52:842–8.CrossRefPubMed Ansari F, Gray K, Nathwani D, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52:842–8.CrossRefPubMed
11.
go back to reference Wickens HJ, Robson R, Griffiths T. A web-based pharmacy to microbiology referral system. Hosp Pharm. 2006;13:131–2. Wickens HJ, Robson R, Griffiths T. A web-based pharmacy to microbiology referral system. Hosp Pharm. 2006;13:131–2.
12.
go back to reference Weeks C, Jones G, Wylie S. Costs and health care benefits of an antimicrobial management programme. Hosp Pharm. 2006;13:179–82. Weeks C, Jones G, Wylie S. Costs and health care benefits of an antimicrobial management programme. Hosp Pharm. 2006;13:179–82.
13.
go back to reference Talpaert MJ, Rao GG, Cooper BS, Wade PA. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66:2168–74.CrossRefPubMed Talpaert MJ, Rao GG, Cooper BS, Wade PA. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66:2168–74.CrossRefPubMed
14.
go back to reference Thakkar K, Gilchrist M, Dickinson E, Benn J, Franklin BD, Jacklin A, et al. A quality improvement programme to increase compliance with an anti-infective prescribing policy. J Antimicrob Chemother. 2011;66:1916–20.PubMedCentralCrossRefPubMed Thakkar K, Gilchrist M, Dickinson E, Benn J, Franklin BD, Jacklin A, et al. A quality improvement programme to increase compliance with an anti-infective prescribing policy. J Antimicrob Chemother. 2011;66:1916–20.PubMedCentralCrossRefPubMed
15.
go back to reference Department of Health. Saving lives—high impact intervention. Care bundle to reduce Clostridium difficile. 2007. Department of Health. Saving lives—high impact intervention. Care bundle to reduce Clostridium difficile. 2007.
16.
go back to reference Department of Health. Clostridium difficile infection: how to deal with the problem. 2008. Department of Health. Clostridium difficile infection: how to deal with the problem. 2008.
17.
go back to reference Public Health England. Clostridium difficile: what it is, how to prevent, how to treat. 2009. Public Health England. Clostridium difficile: what it is, how to prevent, how to treat. 2009.
18.
go back to reference Health Protection Agency. Clostridium difficile infection (CDI): management in care homes. 2010. Health Protection Agency. Clostridium difficile infection (CDI): management in care homes. 2010.
19.
go back to reference Department of Health. Clostridium difficile: updated guidance on diagnosis and reporting. 2012. Department of Health. Clostridium difficile: updated guidance on diagnosis and reporting. 2012.
20.
go back to reference NHS England. Clostridium difficile infection objectives for NHS organisations in 2014/15 and guidance on sanction implementation. NHS England. Clostridium difficile infection objectives for NHS organisations in 2014/15 and guidance on sanction implementation.
25.
go back to reference Department of Health. Antimicrobial stewardship: Start smart—then focus. 2011. Department of Health. Antimicrobial stewardship: Start smart—then focus. 2011.
26.
go back to reference Public Health England. Start smart—then focus: antimicrobial stewardship toolkit for English hospitals. 2015. Public Health England. Start smart—then focus: antimicrobial stewardship toolkit for English hospitals. 2015.
27.
go back to reference Department of Health. Annual progress report and implementation plan (2014) of the UK AMR Strategy 2013–18. 2014. Department of Health. Annual progress report and implementation plan (2014) of the UK AMR Strategy 2013–18. 2014.
28.
go back to reference Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.CrossRefPubMed Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.CrossRefPubMed
29.
go back to reference Dumartin C, Rogues AM, Amadeo B, Pefau M, Venier AG, Parneix P, et al. Antibiotic usage in south-western French hospitals: trends and association with antibiotic stewardship measures. J Antimicrob Chemother. 2011;66(7):1631–7.CrossRefPubMed Dumartin C, Rogues AM, Amadeo B, Pefau M, Venier AG, Parneix P, et al. Antibiotic usage in south-western French hospitals: trends and association with antibiotic stewardship measures. J Antimicrob Chemother. 2011;66(7):1631–7.CrossRefPubMed
30.
go back to reference Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis. 2014;58(3):401–6. Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis. 2014;58(3):401–6.
31.
go back to reference Chen AW, Khumra S, Eaton V, Kong DC. Snapshot of barriers to and indicators for antimicrobial stewardship in Australian Hospitals. J Pharm Pract Res. 2011;41(1):37–41.CrossRef Chen AW, Khumra S, Eaton V, Kong DC. Snapshot of barriers to and indicators for antimicrobial stewardship in Australian Hospitals. J Pharm Pract Res. 2011;41(1):37–41.CrossRef
42.
go back to reference Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015;70:1245–55.PubMed Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015;70:1245–55.PubMed
43.
go back to reference Howard P, Pulcini C, Levy Hara G, Nathwani D, Gould I. Global antimicrobial stewardship survey—interim analysis of UK data. Oral paper 2087. Birmingham: Federation of Infection Societies; 2013. Howard P, Pulcini C, Levy Hara G, Nathwani D, Gould I. Global antimicrobial stewardship survey—interim analysis of UK data. Oral paper 2087. Birmingham: Federation of Infection Societies; 2013.
51.
go back to reference Ashiru-Oredope D, Cookson B, Fry C, on behalf of the Advisory Committee on Antimicrobial R, Healthcare Associated Infection Professional Education S. Developing the first national antimicrobial prescribing and stewardship competences. J Antimicrob Chemother. 2014;69:2886–8. Ashiru-Oredope D, Cookson B, Fry C, on behalf of the Advisory Committee on Antimicrobial R, Healthcare Associated Infection Professional Education S. Developing the first national antimicrobial prescribing and stewardship competences. J Antimicrob Chemother. 2014;69:2886–8.
52.
go back to reference Sneddon J, Gilchrist M, Wickens H. Development of an expert professional curriculum for antimicrobial pharmacists in the UK. J Antimicrob Chemother. 2015;70:1277–80.CrossRefPubMed Sneddon J, Gilchrist M, Wickens H. Development of an expert professional curriculum for antimicrobial pharmacists in the UK. J Antimicrob Chemother. 2015;70:1277–80.CrossRefPubMed
53.
go back to reference Wickens H, Farrell S, Jacklin A, Ashiru-Oredope D, Holmes A. Who trains the trainer? Education of antimicrobial pharmacists. Poster 137. Birmingham: Federation of Infection Societies; 2013. Wickens H, Farrell S, Jacklin A, Ashiru-Oredope D, Holmes A. Who trains the trainer? Education of antimicrobial pharmacists. Poster 137. Birmingham: Federation of Infection Societies; 2013.
54.
go back to reference Simpson SA, Butler CC, Hood K, Cohen D, Dunstan F, Evans MR, et al. Stemming the Tide of Antibiotic Resistance (STAR): a protocol for a trial of a complex intervention addressing the ‘why’ and ‘how’ of appropriate antibiotic prescribing in general practice. BMC Fam Pract. 2009;10:20.PubMedCentralCrossRefPubMed Simpson SA, Butler CC, Hood K, Cohen D, Dunstan F, Evans MR, et al. Stemming the Tide of Antibiotic Resistance (STAR): a protocol for a trial of a complex intervention addressing the ‘why’ and ‘how’ of appropriate antibiotic prescribing in general practice. BMC Fam Pract. 2009;10:20.PubMedCentralCrossRefPubMed
56.
go back to reference Butler CC, Simpson SA, Dunstan F, Rollnick S, Cohen D, Gillespie D, et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ. 2012;344:d8173.PubMedCentralCrossRefPubMed Butler CC, Simpson SA, Dunstan F, Rollnick S, Cohen D, Gillespie D, et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ. 2012;344:d8173.PubMedCentralCrossRefPubMed
59.
go back to reference Wickens HJ, Farrell S, Ashiru-Oredope DA, Jacklin A, Holmes A, In collaboration with the Antimicrobial Stewardship Group of Department of Health Advisory Committee on Antimicrobial Resistance and Health Care Associated Infections (ASG-ARHAI). The increasing role of pharmacists in antimicrobial stewardship in English hospitals. J Antimicrob Chemother. 2013;68(11):2675–81. Wickens HJ, Farrell S, Ashiru-Oredope DA, Jacklin A, Holmes A, In collaboration with the Antimicrobial Stewardship Group of Department of Health Advisory Committee on Antimicrobial Resistance and Health Care Associated Infections (ASG-ARHAI). The increasing role of pharmacists in antimicrobial stewardship in English hospitals. J Antimicrob Chemother. 2013;68(11):2675–81.
60.
go back to reference Jepson A, Wickens H. What does a microbiology pharmacist do? Pharm J. 2003;271:774–5. Jepson A, Wickens H. What does a microbiology pharmacist do? Pharm J. 2003;271:774–5.
61.
go back to reference Knox K, Lawson W, Dean B, Holmes A. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist—a UK perspective. J Hosp Infect. 2003;53(2):85–90.CrossRefPubMed Knox K, Lawson W, Dean B, Holmes A. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist—a UK perspective. J Hosp Infect. 2003;53(2):85–90.CrossRefPubMed
63.
go back to reference Ashiru-Oredope D. A survey of primary care antimicrobial pharmacists. Royal Pharmaceutical Socety conference; 2015. Ashiru-Oredope D. A survey of primary care antimicrobial pharmacists. Royal Pharmaceutical Socety conference; 2015.
64.
go back to reference Kullar R, Goff DA. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin N Am. 2014;28(2):291–300.CrossRef Kullar R, Goff DA. Transformation of antimicrobial stewardship programs through technology and informatics. Infect Dis Clin N Am. 2014;28(2):291–300.CrossRef
65.
go back to reference McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc. 2006;13(4):378–84. McGregor JC, Weekes E, Forrest GN, Standiford HC, Perencevich EN, Furuno JP, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J Am Med Inform Assoc. 2006;13(4):378–84.
66.
go back to reference Wang HY, Lu CL, Wu MP, Huang MH, Huang YB. Effectiveness of an integrated CPOE decision-supporting system with clinical pharmacist monitoring practice in preventing antibiotic dosing errors. Int J Clin Pharmacol Ther. 2012;50(6):375–82.CrossRefPubMed Wang HY, Lu CL, Wu MP, Huang MH, Huang YB. Effectiveness of an integrated CPOE decision-supporting system with clinical pharmacist monitoring practice in preventing antibiotic dosing errors. Int J Clin Pharmacol Ther. 2012;50(6):375–82.CrossRefPubMed
67.
go back to reference Sintchenko V, Coiera E, Gilbert GL. Decision support systems for antibiotic prescribing. Curr Opin Infect Dis. 2008;21(6):573–9.CrossRefPubMed Sintchenko V, Coiera E, Gilbert GL. Decision support systems for antibiotic prescribing. Curr Opin Infect Dis. 2008;21(6):573–9.CrossRefPubMed
68.
go back to reference Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al. Electronic antibiotic stewardship–reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother. 2008;62(3):608–16 (65). Buising KL, Thursky KA, Robertson MB, Black JF, Street AC, Richards MJ, et al. Electronic antibiotic stewardship–reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother. 2008;62(3):608–16 (65).
69.
go back to reference Baysari MT, Oliver K, Egan B, Li L, Richardson K, Sandaradura I, et al. Audit and feedback of antibiotic use: utilising electronic prescription data. Appl Clin Inform. 2013;4(4):583–95.PubMedCentralCrossRefPubMed Baysari MT, Oliver K, Egan B, Li L, Richardson K, Sandaradura I, et al. Audit and feedback of antibiotic use: utilising electronic prescription data. Appl Clin Inform. 2013;4(4):583–95.PubMedCentralCrossRefPubMed
70.
go back to reference Audit Commission. A spoonful of sugar: medicines management in NHS hospitals. 2001. Audit Commission. A spoonful of sugar: medicines management in NHS hospitals. 2001.
72.
go back to reference Curtis C, Marriott J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother. 2004;54(2):529–33.CrossRefPubMed Curtis C, Marriott J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care. J Antimicrob Chemother. 2004;54(2):529–33.CrossRefPubMed
73.
go back to reference Jumaa P, Young I, Nightingale P, Clark I. Audit of the antimicrobial treatment of Clostridium difficile toxin-positive episodes using an integrated electronic prescribing, information and communication system. J Hosp Infect. 2009;72(4):371–3.CrossRefPubMed Jumaa P, Young I, Nightingale P, Clark I. Audit of the antimicrobial treatment of Clostridium difficile toxin-positive episodes using an integrated electronic prescribing, information and communication system. J Hosp Infect. 2009;72(4):371–3.CrossRefPubMed
74.
go back to reference Bignardi GE, Hamson C, Chalmers A. Can we use electronic prescribing to reduce prescription errors for antibiotics? J Infect. 2010;61(5):427–8.CrossRefPubMed Bignardi GE, Hamson C, Chalmers A. Can we use electronic prescribing to reduce prescription errors for antibiotics? J Infect. 2010;61(5):427–8.CrossRefPubMed
75.
go back to reference Cooley N. Personal communication (via Paul Wade) on benefits of e-prescribing from lead antimicrobial pharmacist. London: Chelsea & Westminster NHS Foundation Trust; 2014. Cooley N. Personal communication (via Paul Wade) on benefits of e-prescribing from lead antimicrobial pharmacist. London: Chelsea & Westminster NHS Foundation Trust; 2014.
76.
go back to reference Sheikh A. Personal communication (via Paul Wade) about level of ePrescribing in UK from Professor of Primary Care Research & Development and Chair, eHealth Strategy Group, University of Edinburgh. 2015. Sheikh A. Personal communication (via Paul Wade) about level of ePrescribing in UK from Professor of Primary Care Research & Development and Chair, eHealth Strategy Group, University of Edinburgh. 2015.
77.
go back to reference Micallef C, Aliyu SH, Santos R, Brown NM, Rosembert D, Enoch DA. Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J Antimicrob Chemother. 2015;70(6):1908–11.PubMed Micallef C, Aliyu SH, Santos R, Brown NM, Rosembert D, Enoch DA. Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England. J Antimicrob Chemother. 2015;70(6):1908–11.PubMed
78.
go back to reference Parkinson C, Gilchrist M, Armstrong-James, D, Whitney L, Bicanic T. Sharing and developing a consensus approach to antifungal stewardship in London— a proof of concept (poster). Harrogate: Federation of Infection Societies; 2014. Parkinson C, Gilchrist M, Armstrong-James, D, Whitney L, Bicanic T. Sharing and developing a consensus approach to antifungal stewardship in London— a proof of concept (poster). Harrogate: Federation of Infection Societies; 2014.
79.
go back to reference Chapman ALN, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–24. Chapman ALN, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–24.
80.
go back to reference Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. J Antimicrob Chemother. 2015;70(4):965–70.PubMed Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. J Antimicrob Chemother. 2015;70(4):965–70.PubMed
81.
go back to reference Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053–62.CrossRefPubMed Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053–62.CrossRefPubMed
82.
go back to reference Patel S, Abrahamson E, Goldring S, Green H, Wickens H, Laundy M. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360–73.CrossRefPubMed Patel S, Abrahamson E, Goldring S, Green H, Wickens H, Laundy M. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360–73.CrossRefPubMed
83.
go back to reference Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents. 2011;38(1):16–26.CrossRefPubMed Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents. 2011;38(1):16–26.CrossRefPubMed
Metadata
Title
Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists
Authors
Mark Gilchrist
Paul Wade
Diane Ashiru-Oredope
Philip Howard
Jacqueline Sneddon
Laura Whitney
Hayley Wickens
Publication date
01-09-2015
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue Special Issue 1/2015
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-015-0080-z

Other articles of this Special Issue 1/2015

Infectious Diseases and Therapy 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.